Inflammatory disease which causes the smaller bones of the spine to amalgamate with one another is called Ankylosing Spondylitis. This affects the flexibility of the spines and can end up in a hunched-forward posture. In this condition, if the ribs are labored it makes it difficult in breathing.

Ankylosing Spondylitis is shown more dominantly in men as compared to women. The symptoms for Ankylosing Spondylitis are observed in early adulthood. This inflammation can take place in other parts like the eyes of the person.

At present, cure has not been found for Ankylosing Spondylitis. Having said that, the treatments for Ankylosing Spondylitis help steady and slower the disease progression and helps to lower the symptoms.

The symptoms of the Ankylosing Spondylitis encompass the stiffness in the hips and lower back which is generally observed after inactivating sessions of the person or in the mornings. Along with this fatigue and pain in the neck are also observed. Additionally, there are some other symptoms as well which are irregular in the expression.

The organs most affected by Ankylosing Spondylitis include:

• Shoulder and hip joints
• Lower back vertebrae
• Joints in the pelvis and the spine

Market scope and structure analysis:

COVID-19 scenario analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.

Owing to such factors, COVID 19 is expected to have a significant impact on the Ankylosing Spondylitis market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

As there are no therapies approved yet for the Ankylosing Spondylitis it can be said that the market is still in the growing phase. The treatment available in the market generally focuses on minimizing the discomfort caused. As there has been a rise in the R & D activities and their funding, and the number of patients all over the world seeking for a treatment will surely help the market in propelling further.

Research for finding a cure; advances in the treatment procedures and techniques, along with the increasing awareness for the major factoring affecting the growth of the Ankylosing Spondylitis treatment market. Moreover, the initiatives taken by the government for the betterment of the healthcare facilities are creating new opportunities for the Ankylosing Spondylitis market.

On the other hand, many products are losing their patent like the etanercept, and the introduction of biosimilar products are the major challenges faced by the Ankylosing Spondylitis market.

New product launches and acquisitions to flourish the market:

On July 14th, 2019, Gilead Sciences, Inc. and Galapagos NV introduced a new product in the market named Filgotinib which helps in indicating the severity of the active Ankylosing Spondylitis.

On June 26th, 2019, Humira which is a blockbuster drug for Abbvie Inc. received a patent extension till the year 2023 for the states of the U.S.

On November 16th, 2019, Abrilada which is a biosimilar for Humira received approval from the U. S. FDA.

On October 24th, 2019, the European Commission approved Cosentyx which is a product non-radiographic axial spondyloarthritis launched by Novartis.

Surge in usage in hospitals applications:

Hospitals pharmacies, online pharmacies, and retail pharmacies are the major consumers of the Ankylosing Spondylitis market. Amongst them, the hospital pharmacies are the biggest end-users of the market. Additionally, there has been a significant growth observed in the online pharmacies and the new trend is capturing more attention of the population towards these online pharmacies. This growth is due to the convenience, better offers, and the comfort associated with the online pharmacies.

Key segments covered:

Key benefits of the report:

• This study presents the analytical depiction of the global Ankylosing Spondylitis industry along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global market share.
• The current market is quantitatively analyzed from 2020 to 2027 to highlight the global market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
• The report provides a detailed global Ankylosing Spondylitis market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Ankylosing Spondylitis Market research report:

• What are the leading market players active in the Ankylosing Spondylitis market?
• What the current trends will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities in the market?
• What are the projections for the future that would help in taking further strategic steps?